Official Publication of the Society for Laboratory Automation and Screening
This message contains images. If you don't see images, click here to view.
Advertise in this news brief.


Text version   RSS   Subscribe   Unsubscribe   Archive   Media Kit February 28, 2018    SLAS2018    Moving? New job? Let SLAS know.      







From the SLAS President: SLAS is Where Innovation and Collaboration are Commonplace
SLAS     Share    Share on FacebookTwitterShare on LinkedinE-mail article
"What a great time to become SLAS president!" says SLAS President Sabeth Verpoorte, Ph.D., in the SLAS Electronic Laboratory Neighborhood e-zine. In her inaugural message, Verpoorte thanks those whose continuing support made SLAS2018 a roaring success with its record-smashing attendance (more than 6,600 attendees from 40 countries).

"I have always known SLAS to be the community where innovation is plentiful and collaboration is commonplace, and I am truly grateful for the opportunity to help direct the future of this Society," says Verpoorte. Looking to the future, she describes ongoing opportunity for SLAS to deliver continuing success to another continent with the 2018 SLAS Europe Conference and Exhibition, June 27-29, Brussels, Belgium.


Call for Papers: Academic Screening Centers & Translational Drug Discovery Centers Showcase
SLAS    Share    Share on FacebookTwitterShare on LinkedinE-mail article
SLAS Discovery seeks original research papers, technical notes or reviews that focus on science in the context of academic screening and drug discovery endeavors for a special issue led by guest editor Marc Bickle of the Max Planck Institute of Molecular Cell Biology and Genetics (Dresden, Germany). An in-depth editorial will describe each laboratory and its operational model. Manuscript proposals (abstracts) are due by May 1, and invited papers will then be due Aug. 1. More

One Week until the 2018 SLAS Europe Compound Management Conference
SLAS     Share    Share on FacebookTwitterShare on LinkedinE-mail article
Register now for this exclusive forum for compound and sample management professionals! The 2018 SLAS Europe Compound Management Conference starts next week, March 8-9 in Berlin, Germany. Bench scientists to senior managers benefit by learning how peers manage processes, apply quality control and develop successful collaborations. Come see the latest novel technology solutions in IT and hardware, as well as a vendor session featuring best-in-class solutions. More

Sponsored Content

SLAS Journals Welcome New Editorial Board Members
SLAS     Share    Share on FacebookTwitterShare on LinkedinE-mail article
SLAS is grateful to the more than 1,000 volunteer authors, peer reviewers and editors whose efforts enable the annual publication of 16 issues of its journals. Members of the SLAS editorial boards serve as frontline advocates, sharing their energy and expertise to help attract and assess high-quality contributions for publication. Joining the boards in 2018 are:

SLAS Discovery
Jeroen Kool, Ph.D., Vrije Universiteit Amsterdam (The Netherlands)
Andreas Vogt, Ph.D., University of Pittsburgh Drug Discovery Institute, Pittsburgh, PA (USA)

SLAS Technology
Heidi Fleischer, P.D. Dr.-Ing. habil., Institute of Automation, University of Rostock (Germany)
Michael Santillo, Ph.D., U.S. Food and Drug Administration, Laurel, MD (USA)

The SLAS journals are backed by the high-quality education standards of SLAS and PubMed: MEDLINE indexed. NO article processing charges (APCs). Open access options are available. Manuscripts accepted from SLAS members and nonmembers.

Seize the Moment! One Month Remains for 2018 SLAS Europe Conference and Exhibition Registration Discounts
SLAS     Share    Share on FacebookTwitterShare on LinkedinE-mail article
Join life sciences discovery and technology professionals at the inaugural 2018 SLAS Europe Conference and Exhibition, June 27-29, 2018, in Brussels, Belgium. Register now to learn the latest about hot topics such as organoids, iPS derived models and the use of precise gene editing technologies such as TALEN and CRISPR. Explore the biological mechanisms involved in aging and degenerative disease, target biology and achieving meaningful knowledge from big data. Keynote speakers include futurist Peter Hinssen of nexxworks (Ghent, Belgium), life sciences collaboration thought leader Mathias Uhlén of the Karolinska Institute (Stockholm, Sweden) and policy maker Max Lemke, Components and Systems of the European Commission (Brussels, Belgium). More

Essential Steps to Better Collaboration

Because drug discovery involves scientists from multiple disciplines and often organizations, it is critical to have an efficient mechanism for researchers to collaborate and realize the collective value of their specialized knowledge, assets, and capabilities. This free white paper details the essential keys to effective collaboration.

On the Road with the SLAS CEO: Sunshine and Success in San Diego
SLAS     Share    Share on FacebookTwitterShare on LinkedinE-mail article
Take a trip to San Diego with SLAS CEO Vicki Loise's latest blog post. She shines a spotlight on SLAS2018, sharing facts and figures from the record-breaking 2018 SLAS International Conference and Exhibition. "It takes a committed team of staff and volunteers to pull off an event like this. And for SLAS2018, this group excelled at every point," Loise says. She also reveals future plans for the 2018 SLAS Europe Conference and Exhibition to be held June 27-29, 2018, in Brussels, "If you work or do business in Europe or are looking to expand your reach in Europe — this is a cannot miss event!" More

New Year, New Job Resolution? Seek the Perfect Position with SLAS Career Connections
SLAS     Share    Share on FacebookTwitterShare on LinkedinE-mail article
New career opportunities await! Visit SLAS Career Connections for a targeted employment exchange where job seekers can post resumes and browse job openings for free. Employers can find new talent by reviewing posted resumes for free and attract new talent by posting job openings for a fee. SLAS Corporate Members receive a 50% discount on job postings. More

AMRI’s integrated drug discovery centers of excellence combine scientific expertise and leading-edge technology to accelerate innovation. Our complete suite of solutions includes comprehensive discovery biology, synthetic and medicinal chemistry, DMPK and bioanalytical services for successful hit-to-lead-to-candidate selection.

Contact us to put our Discovery expertise to work for you, contact:


Flu Drug Approved in Japan Claims to Stop Virus in 24 Hours
The Scientist    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Health authorities in Japan approved a new flu medication, called baloxavir marboxil (Xofluza), that aims to stop the virus within one day, according to The Wall Street Journal. The drug works by blocking the flu virus' ability to use the host cell for replication. That's a different mechanism from oseltamivir (Tamiflu), an anti-influenza medication available in the U.S. that works by blocking the virus' neuraminidase enzyme, preventing its escape from the host cell. More

Going With the DNA Flow: Molecule of Life Finds New Uses in Microelectronics    Share    Share on FacebookTwitterShare on LinkedinE-mail article
For sheer versatility, there's no molecule quite like DNA. The iconic double-helix carries the genetic blueprint for living forms ranging from single-celled organisms to human beings. Recently, researchers have found that DNA's remarkable properties of self-assembly and its ability to conduct electrical charge over considerable distance make it ideally suited for myriad applications, including tiny electronic circuits and computing devices, nanorobots and new advances in photonics. More

Using Light and Gold Nanoparticles for Targeted, Non-Invasive Drug Delivery
Lab Manager    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Over the last century, there has been astounding progress in medical science, leading to the development of efficient, effective medications for treating cancer and a wide variety of other diseases. But the random dispersion of drugs throughout the body often lowers their effectiveness and, even worse, damages healthy tissue. A prime example of this is the use of chemotherapy drugs. More

Glycomimetic, Orally Bioavailable LecB Inhibitors Block Biofilm Formation of Pseudomonas aeruginosa
Journal of the American Chemical Society    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The opportunistic Gram-negative bacterium Pseudomonas aeruginosa is a leading pathogen for infections of immuno-compromised patients and those suffering from cystic fibrosis. Its ability to switch from planktonic life to aggregates, forming the so-called biofilms, is a front-line mechanism of antimicrobial resistance. The bacterial carbohydrate-binding protein LecB is an integral component and necessary for biofilm formation. More

Melanoma Spread May Be Averted with Repurposed Leukemia Drugs
Genetic Engineering & Biotechnology News    Share    Share on FacebookTwitterShare on LinkedinE-mail article
At the University of Kentucky, scientists have identified a molecular mechanism behind the spread of melanoma. Better, the scientists say that interfering with the mechanism could prevent nonmetastatic melanoma from becoming highly aggressive metastatic melanoma. Better still, the scientists point out that the mechanism could be inhibited by drugs that already exist. More

Custom Stem Cell Treatment Could Offer MS Relief
Bioscience Technology    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Scientists have shown in mice that skin cells re-programmed into brain stem cells, transplanted into the central nervous system, help reduce inflammation and may be able to help repair damage caused by multiple sclerosis. The study, led by researchers at the University of Cambridge, is a step towards developing personalized treatments based on a patient's own skin cells for diseases of the central nervous system. More

Watch a Wound Close With the Help of Fat Cells
Science Magazine    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Fat gets a bad rap, but it may be critical to wound healing, a new study suggests. Researchers fluorescently labeled fat cells in fruit fly pupae — the developmental stage between larva and adult — and then cut a small hole in the pupae with a laser. Within an hour, the fat cells had swum toward the wound, the team reports in Developmental Cell. Actomyosin, a protein complex responsible for cellular contractions, was responsible for the fat cells' wormlike propulsion. More


Product Specialist, Automation
Labcyte, Inc.
US – CA – San Jose

Postdoctoral Research Fellow High Content Imaging
Merck Sharpe & Dohme Corp.
US – PA – West Point

Automation Engineer III/Sr. Automation Engineer
Cytokinetics, Inc.
US – CA – South San Francisco

Search Jobs at SLAS Career Connections



SLAS Point-to-Point
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Dennis Hall, Executive Editor, 469.420.2656   
Contribute news

This edition of SLAS Point-to-Point was sent to ##Email##. To unsubscribe from receiving SLAS Point-to-Point, click here. To unsubscribe from all SLAS e-mail communications, please click here. Did someone forward this edition to you? Subscribe here — it's free!

SLAS Terms of Use Policy

MultiView Privacy Policy 

Recent issues

Feb. 21, 2018
Feb. 14, 2018
Feb. 7, 2018
Jan. 31, 2018

7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063